CAPR NASDAQ
Capricor Therapeutics, Inc.
1W: -66.8%
1M: -75.2%
3M: -81.3%
YTD: -76.8%
1Y: -6.9%
3Y: +44.4%
5Y: +31.7%
$6.57
-0.42 (-6.08%)
Weekly Expected Move ±9.5%
$16
$18
$20
$22
$23
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$380.5M
52W Range4.3-40.37
Volume16,251,206
Avg Volume1,330,325
Beta0.42
Dividend—
Analyst Ratings
Company Info
CEOLinda Marbán
Employees231
SectorHealthcare
IndustryBiotechnology
IPO Date2007-02-13
Websitecapricor.com
10865 Road to the Cure
San Diego, CA 92121
US
San Diego, CA 92121
US
310 358 3200
About Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (âDMDâ), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Latest News
Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel
Capricor Therapeutics Sees Unusually High Options Volume (NASDAQ:CAPR)
This Capricor Insider Sold 24,000 Shares Before the Drop. With a New Catalyst on the Way, Is It Time to Buy?
CAPR - Capricor Therapeutics - 100%+ Short Float of Retail Shares - Long Setup
Capricor - FDA Insight and New Headquarter Long Term Lease
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Krasney Karen | S-Sale | 24,100 | $30.38 | 2026-06-25 |
| Bergmann Anthony | S-Sale | 24,100 | $30.38 | 2026-06-25 |
| Krasney Karen | S-Sale | 400 | $30.00 | 2026-06-24 |
| Bergmann Anthony | S-Sale | 400 | $30.00 | 2026-06-24 |
| Maurer Michael T | A-Award | 80,000 | $29.36 | 2026-05-26 |